Morgan Stanley sees “an opportune entry point” into Keurig Dr Pepper (KDP), arguing that the market not recognizing better near-term visibility than investor fears, as well as relative to consumer package goods peers, and building visibility of long-term organic sales growth outperformance has created a “very compelling valuation.” The firm’s 20% base case for upside is predicated mainly on continued strength in U.S. Refreshment/International, which are three-quarters of profit combined, notes the analyst, who has an Overweight rating and $40 price target on Keurig Dr Pepper shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Coca-Cola Partners With Universal Music to Debut Real Thing Records
- Keurig Dr Pepper Declares Quarterly Dividend Announcement
- Coca-Cola Embraces Viral TikTok Trend With Sprite+Tea
- Keurig Dr Pepper’s Strong Sales Growth and Promising Financial Outlook Earns Buy Rating
- Keurig Dr Pepper’s Strong U.S. Momentum and Strategic Investments Drive Buy Rating